These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1672971)

  • 1. Biotype as determinant of natural immunising effect of cholera.
    Clemens JD; van Loon F; Sack DA; Rao MR; Ahmed F; ChakrabortY J; Kay BA; Khan MR; Yunus MD; Harris JR
    Lancet; 1991 Apr; 337(8746):883-4. PubMed ID: 1672971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural cholera infection-derived immunity in an endemic setting.
    Ali M; Emch M; Park JK; Yunus M; Clemens J
    J Infect Dis; 2011 Sep; 204(6):912-8. PubMed ID: 21849288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.
    Clemens J; Rao M; Sack D; Ahmed F; Khan MR; Chakraborty J; Kay B; Huda S; Yunus M; van Loon F
    Am J Epidemiol; 1995 Oct; 142(7):759-64. PubMed ID: 7572947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The design and analysis of cholera vaccine trials: recent lessons from Bangladesh.
    Clemens J; Sack D; Rao M; Chakraborty J; Kay B; Ahmed F; Khan MR; van Loon FP; Svennerholm AM; Holmgren J
    Int J Epidemiol; 1993 Aug; 22(4):724-30. PubMed ID: 8225749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area.
    Clemens JD; Sack DA; Rao MR; Chakraborty J; Khan MR; Kay B; Ahmed F; Banik AK; van Loon FP; Yunus M
    J Infect Dis; 1992 Nov; 166(5):1029-34. PubMed ID: 1402014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.
    Glass RI; Svennerholm AM; Khan MR; Huda S; Huq MI; Holmgren J
    J Infect Dis; 1985 Feb; 151(2):236-42. PubMed ID: 3968450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous classical and El Tor cholera in Bangladesh.
    Khan MU; Samadi AR; Huq MI; Yunus M; Eusof A
    J Diarrhoeal Dis Res; 1984 Mar; 2(1):13-8. PubMed ID: 6501815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.
    Taylor DN; Cárdenas V; Sanchez JL; Bégué RE; Gilman R; Bautista C; Perez J; Puga R; Gaillour A; Meza R; Echeverria P; Sadoff J
    J Infect Dis; 2000 May; 181(5):1667-73. PubMed ID: 10823767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae.
    Tacket CO; Losonsky G; Nataro JP; Cryz SJ; Edelman R; Fasano A; Michalski J; Kaper JB; Levine MM
    J Infect Dis; 1993 Dec; 168(6):1536-40. PubMed ID: 8245542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of classic cholera in Bangladesh.
    Siddique AK; Baqui AH; Eusof A; Haider K; Hossain MA; Bashir I; Zaman K
    Lancet; 1991 May; 337(8750):1125-7. PubMed ID: 1674016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An epidemic of cholera due to Vibrio cholerae O139 in Dhaka, Bangladesh: clinical and epidemiological features.
    Mahalanabis D; Faruque AS; Albert MJ; Salam MA; Hoque SS
    Epidemiol Infect; 1994 Jun; 112(3):463-71. PubMed ID: 8005212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial.
    Qadri F; Ali M; Lynch J; Chowdhury F; Khan AI; Wierzba TF; Excler JL; Saha A; Islam MT; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Khan IA; Kabir A; Riaz BK; Akter A; Khan A; Asaduzzaman M; Kim DR; Siddik AU; Saha NC; Cravioto A; Singh AP; Clemens JD
    Lancet Infect Dis; 2018 Jun; 18(6):666-674. PubMed ID: 29550406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of a new epidemic strain of Vibrio cholerae in Bangladesh. An epidemiological study.
    Siddique AK; Zaman K; Akram K; Mutsuddy P; Eusof A; Sack RB
    Trop Geogr Med; 1994; 46(3):147-50. PubMed ID: 7941003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR.
    Albert MJ; Alam K; Ansaruzzaman M; Qadri F; Sack RB
    J Infect Dis; 1994 Jan; 169(1):230-1. PubMed ID: 8277193
    [No Abstract]   [Full Text] [Related]  

  • 16. Cholera outbreaks in the classical biotype era.
    Siddique AK; Cash R
    Curr Top Microbiol Immunol; 2014; 379():1-16. PubMed ID: 24368696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Cholera Working Group, International Centre for Diarrhoeal Diseases Research, Bangladesh.
    Lancet; 1993 Aug; 342(8868):387-90. PubMed ID: 8101899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of antibody responses and protective immunity in cholera vaccinated subjects.
    Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PaxVax CVD 103-HgR single-dose live oral cholera vaccine.
    Levine MM; Chen WH; Kaper JB; Lock M; Danzig L; Gurwith M
    Expert Rev Vaccines; 2017 Mar; 16(3):197-213. PubMed ID: 28165831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-O1 Vibrio cholerae and epidemic cholera.
    Commun Dis Rep CDR Wkly; 1993 Jun; 3(24):107. PubMed ID: 7693194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.